Related Experiment Videos
Determining modes of action for biologically based risk assessments
1Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709, USA.
Regulatory Toxicology and Pharmacology : RTP
|August 28, 1999
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Evaluation of Therapeutics for Advanced-Stage Heart Failure and Other Severely-Debilitating or Life-Threatening Diseases.
Clinical pharmacology and therapeutics·2017
Using physiologically based pharmacokinetic modeling and benchmark dose methods to derive an occupational exposure limit for N-methylpyrrolidone.
Regulatory toxicology and pharmacology : RTP·2016
An evaluation of in vivo models for toxicokinetics of hexavalent chromium in the stomach.
Toxicology and applied pharmacology·2015
Physiologically based pharmacokinetic model use in risk assessment--Why being published is not enough.
Toxicological sciences : an official journal of the Society of Toxicology·2011
Validation of human physiologically based pharmacokinetic model for vinyl acetate against human nasal dosimetry data.
Toxicological sciences : an official journal of the Society of Toxicology·2005
Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate.
Annual review of pharmacology and toxicology·2002
Polyaromatic Hydrocarbon Driven Developmental Toxicity is Dependent on the Aryl Hydrocarbon Receptor: A case study with Benzo(a)Pyrene.
Regulatory toxicology and pharmacology : RTP·2026
A Decision Tree for Acute Oral Toxicity: Implementing the Last Resort Requirement in Practice.
Regulatory toxicology and pharmacology : RTP·2026
Toxicological Assessment of Potential Leachables in Parenteral Drug Products: Bioavailability Adjustment Considerations.
Regulatory toxicology and pharmacology : RTP·2026
New approach methodologies in food safety: A survey and commentary on industry adoption, barriers, and the path to regulatory adoption.
Regulatory toxicology and pharmacology : RTP·2026
Overcoming Difficult, Impossible, and Meaningless Animal Testing under REACH: Opportunities for Robust Chemical Risk Assessment with Non-Animal Approaches.
Regulatory toxicology and pharmacology : RTP·2026
BRIGHTLINE-1: When a Negative Trial Reveals Two Active Therapies.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
CAR T Cells Targeting an Intracellular Leukemia Antigen Promiscuously Presented by Diverse HLA-II Alleles.
Blood cancer discovery·2026
Impact of GAD-65 Antibody Detection on Antihyperglycemic Therapy in T2D.
Endocrine connections·2026